All research papers

Corrigendum: Occupational radiation exposure in spine surgery: organ-specific OSL phantom dosimetry and workload-based risk assessment (2026 J. Radiol. Prot. 46 031510).

Integrated spatiotemporal assessment of ambient radiation fields in a nuclear medicine department using OSL and time-resolved Geiger-Müller monitoring.

The State of the Art of Theranostics and Its Future.

Monitoring Hearing Function in Patients With Sporadic Vestibular Schwannoma: A Feasibility Study to Inform a Future Randomized Controlled Trial.

Quality of life and pain-response after stereotactic ablative radiotherapy of oligometastatic bone metastases in the phase 2 BONY-M trial.

How robust are secondary dose algorithms for Patient-Specific quality assurance in modulated stereotactic Radiosurgery?

Dosimetry-Driven Personalization of Radiopharmaceutical Therapies: Evidence and Opportunities.

Are Urooncologists Onboard?

Baseline serum carcinoembryonic antigen (CEA) is an independent prognostic biomarker for metastatic castration-resistant prostate cancer (mCRPC) patients receiving 177Lu-PSMA therapy.

Fibroblast Activation Protein Inhibitor Positron Emission Tomography Imaging in Atrial Fibrillation: Current Evidence and Future Perspectives.

Dose accuracy evaluation of multi-leaf collimator modeling in single-isocenter multi-target stereotactic radiosurgery.

Quantitative Thresholds on ¹⁸F-DCFPyL PET for Determining Malignancy in Prostate Cancer with Pathologic Correlation.

Association of Atherosclerosis [⁶⁸Ga]Ga-FAPI-04 Uptake with Calcified Plaque Burden and Cardiovascular Risk Factors: Comparison with [¹⁸F]FDG PET/CT.

Optimization, automation and validation of NOP receptor PET radiopharmaceutical, [¹¹C]NOP-1A for human use.

Real-time tumor tracking for magnetic resonance-guided radiotherapy using label-efficient foundation model adaptation.

Deep learning-based approaches for attenuation correction in [¹⁸F]FDG PET: Current advances and future directions.

Dose-Registered CT assessment of radiation-induced lung injury after chemoradiotherapy for stage III NSCLC.

Dosimetric validation of proton beam deflection and field shape deformation in a measured transverse magnetic field of an in-beam MR scanner using a novel dose calculation functionality in a research version of a commercial treatment planning system

Tumor-Related Trigeminal Neuralgia: Clinical Features, Pathophysiology, and the Contemporary Role of Radiosurgery in Tumor Control and Pain Relief

Cherenkov-excited fluorescence imaging for small-field dosimetry and SRS plan verification: a feasibility study

Cell Surface Expression and PET Imaging Establish DLL3 as a Clinically Actionable Target in Neuroblastoma

Adaptive workflow with EQD2 conversion for side effect prediction in prostate re-irradiation.

177Lu-FAPI-2286 Radioligand Therapy in Refractory Scalp Melanoma.

A Novel Technique for Filtration and Dispensing of99mTc Pertechnetate Injection ​

Self-cascade latent Schrödinger bridge for CT field-of-view extension.

Qualitative MRI-Based Assessment of Hydrogel Spacer Distribution Predicts Rectal Dosimetry and Acute Toxicity in Prostate Stereotactic Body Radiotherapy

Magnetic-Field-Induced Secondary-Electron Effects in MR-Guided Radiotherapy: From Dosimetric Mechanisms to Workflow-Based Clinical Risk Management.

Phase 1 Study of Online Proton Adaptive RadioTherapY (PARTY).

Interpretable four-class machine learning prediction of initial I-131 therapy responses in differentiated thyroid cancer.

Pregnancy in a patient with metastatic functioning midgut neuroendocrine tumor receiving lanreotide after peptide receptor radionuclide therapy.

Tumor-Intrinsic Blood and Imaging Correlatives in Advanced Prostate Cancer Treated with Combination Radiopharmaceutical Therapy and Immunotherapy.

SBRT for Colorectal Cancer Liver Metastasis Is a Safe and Effective Treatment Option-A Single Institution Retrospective Analysis.

Patient selection for primary staging with [99mTc]Tc-PSMA SPECT/CT: influence of combined PSA and ISUP grade on detection of metastatic disease.

PSMA-PET Tumor Volume Stratifies Nonmetastatic Castration-resistant Prostate Cancer.

Synergistic role of molecular imaging and genomics in thyroid cancer management: from diagnosis to personalized treatment.

Impact of 18F-DCFPyL-PSMA PET/CT on Radiotherapy Planning and Treatment Intensification in Occult Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy.

Utility of 99mTc-FAPI-46 SPECT/CT in Restaging Hepatocellular Carcinoma: A Case Report.

¹⁷⁷Lu-PSMA Radioligand Therapy in Metastatic Castration-resistant Prostate Cancer With Complex Renal Conditions: A Case Series.

Low-Dose Radiation-Induced Expression of Exosomal miRNAs in the Serum of Medical Radiation Workers.

Radiation-free or Chemo-free: Rethinking the Best Strategy for PD-L1-High, Unresectable Stage III NSCLC.

Occult Maxillary Sinus Phosphaturic Mesenchymal Tumor Localized by 68Ga-DOTATATE PET/CT After Repeated Negative Parathyroid Imaging.

[¹⁸F]AlF-FAPI-74 PET/CT for preoperative assessment of the peritoneal cancer index and comparison with MRI-based, surgical and pathological assessment in colorectal cancer patients eligible for CRS-HIPEC: study protocol for a prospective observational proof-of-concept study.

Spatial distribution of X-ray attenuation in a full-face shield: a multipoint in vivo study in interventional cardiology.

Stereotactic radiosurgery for brain metastases from male breast cancer: a multicenter retrospective study.

Glypican-3-Targeted Paired Radiotheranostics in Orthotopic Liver Cancer Models.

Tumour-to-Kidney Absorbed Dose Ratios for Alpha-Emitter PRRTs Estimated with [¹⁷⁷Lu]Lu-DOTATATE SPECT Images and Biokinetic Models: Patient Variations Impact Contribution from Redistributing Daughters.

Recurrent C19MC-altered embryonal tumors with multilayered rosettes: outcomes of stereotactic radiosurgery.

Stereotactic Radiosurgery for Thalamic Brain Metastases: A Retrospective Analysis and Literature Review.

Final Results From a Phase I Dose Escalation Study (DESTROY-1) in Stereotactic Boost After Prior Radiotherapy.

Incidental Glioblastoma Multiforme Detected on 18F-DCFPyL PET/CT Prostate Cancer Staging.

Diagnostic Superiority of 68Ga-FAPI PET/CT Over 18F-FDG in Restaging of Advanced Epithelioid Sarcoma.

Comparative Evaluation of [99mTc]Tc-HYNIC-FAPI-04 and [99mTc]Tc-HYNIC-FAPI-46 for FAP-Targeted SPECT Imaging.

Dual-Target Nectin-4/FAP Heterobivalent Probe ⁶⁸Ga/¹⁷⁷Lu-FZ-NF-1 for Triple-Negative Breast Cancer: Preclinical Theranostic Evaluation and First-in-Human Translation.

Somatostatin Receptor-Expressing Hibernoma Mimicking Malignancy on SSTR-PET in MEN1: A Diagnostic Pitfall.

Extraskeletal Ewing Sarcoma Involving the Abdominal Cavity and Retroperitoneum on 18F-FDG PET/CT and 68Ga-FAPI-04 PET/CT.

Editorial: Diagnosis, treatment and prognosis of neuroendocrine neoplasms with a focus on peptide receptor radionuclide therapy (PRRT)

Fulminant extramedullary relapse of multiple myeloma with rare cardiac, vascular, and multivisceral involvement: A case report.

LINAC-based stereotactic radiosurgery targeting the hippocampus in mesial temporal lobe epilepsy: a single-center case series.

Dual‐Target Nectin‐4/FAP Heterobivalent Probe 68Ga/177Lu‐FZ‐NF‐1 for Triple‐Negative Breast Cancer: Preclinical Theranostic Evaluation and First‐in‐Human Translation

Heterobivalent fibroblast activation protein-targeted Radiotheranostic ligands integrating cyclic peptide and small-molecule motifs for enhanced tumor retention.